Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Semaglutide has CV outcomes evidence for certain patients
As of 2026, Retatrutide is progressing through Phase 3 clinical trials, with high anticipation for its potential approval as a therapeutic agent
Whichever you choose, youll receive the same high standard of care from our expert medical team
When discussing tirzepatide with donation center staff, donors should specify: the brand name (Mounjaro or Zepbound), current dosage (ranging from 2.5 mg to 15 mg weekly), duration of therapy, indication for use (type 2 diabetes or chronic weight management), and any recent dosage changes
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
